Sustainable Development Goal (SDG) 3.3 is to ‘end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases, and other communicable diseases’ by 2030.
This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 3-9 March 2024 and includes updates on SARS-CoV-2 variant classification, sexually transmitted infections, Psittacosis cases, product safety recall of InterPharma Sodium Chloride 0.9% 30ml linked to Ralstonia pickettii contamination, cholera and Middle East respiratory syndrome coronavirus (MERS-CoV).
This report provides an overview of the latest tuberculosis (TB) epidemiological situation and is published jointly by the WHO Regional Office for Europe and ECDC.
Reaching and testing those at risk of infection with HIV, hepatitis B or C, and sexually transmitted infections (STIs) is still a public health challenge in Europe.
In this report, we provide an overview of the data reported by countries in the EU and EEA in 2023 to describe progress towards the 2025 interim targets for hepatitis elimination as outlined in the WHO European Region Action Plan 2022–2030.
ECDC and WHO/Europe have issued a statement announcing that the European Region remains a long way from meeting its End Tuberculosis Strategy targets, despite having the tools to do so.
For 2020, 29 countries in the European Union/European Economic Area (EU/EEA) reported a total of 33 148 tuberculosis (TB) cases (7.3 per 100 000 population).